NASDAQ:HHS - Nasdaq - US4161962026 - Common Stock - Currency: USD
NASDAQ:HHS (2/21/2025, 8:25:34 PM)
5.05
-0.14 (-2.7%)
The current stock price of HHS is 5.05 USD. In the past month the price decreased by -5.61%. In the past year, price decreased by -35.59%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TTD | TRADE DESK INC/THE -CLASS A | 43.67 | 35.57B | ||
OMC | OMNICOM GROUP | 10.21 | 16.17B | ||
WPP | WPP PLC-SPONSORED ADR | 8.11 | 10.24B | ||
IPG | INTERPUBLIC GROUP OF COS INC | 9.74 | 10.08B | ||
MGNI | MAGNITE INC | 27.2 | 2.49B | ||
CRTO | CRITEO SA-SPON ADR | 9.12 | 2.31B | ||
IBTA | IBOTTA INC-CL A | 593.18 | 2.00B | ||
IAS | INTEGRAL AD SCIENCE HOLDING | 51.85 | 1.69B | ||
STGW | STAGWELL INC | 9.84 | 1.68B | ||
EEX | EMERALD HOLDING INC | N/A | 858.61M | ||
ADV | ADVANTAGE SOLUTIONS INC | N/A | 785.84M | ||
THRY | THRYV HOLDINGS INC | N/A | 778.63M |
Harte-Hanks, Inc. is a global customer experience company operating in three business segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services. The company is headquartered in Chelmsford, Massachusetts and currently employs 1,709 full-time employees. The firm operates through four segments: Marketing Services; Customer Care, Sales Service, and Fulfillment & Logistics Services. Marketing Services segment leverages data, insight, and experience to support clients as they engage customers through digital, traditional, and emerging channels. Customer Care segment offers responsive contact center solutions, which use real-time data to interact with each customer. Customer contacts are handled through phone, e-mail, social media, text messaging, chat, and digital self-service support. Sales Services segment enables customers to optimize their go-to-market function by offering a range of outsourced services including sales process optimization, sales play development, inbound lead qualification and outbound sales prospecting. Fulfillment & Logistics segment consists of mail and product fulfillment and logistics services.
HARTE-HANKS INC
1 Executive Drive, Suite 303
Chelmsford MASSACHUSETTS 78728 US
CEO: Andrew Benett
Employees: 1836
Company Website: https://www.hartehanks.com/
Investor Relations: http://investors.hartehanks.com/index.cfm
Phone: 15124341100
The current stock price of HHS is 5.05 USD. The price decreased by -2.7% in the last trading session.
The exchange symbol of HARTE-HANKS INC is HHS and it is listed on the Nasdaq exchange.
HHS stock is listed on the Nasdaq exchange.
5 analysts have analysed HHS and the average price target is 17.85 USD. This implies a price increase of 253.47% is expected in the next year compared to the current price of 5.05. Check the HARTE-HANKS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HARTE-HANKS INC (HHS) has a market capitalization of 36.81M USD. This makes HHS a Nano Cap stock.
HARTE-HANKS INC (HHS) currently has 1836 employees.
HARTE-HANKS INC (HHS) has a resistance level at 5.1. Check the full technical report for a detailed analysis of HHS support and resistance levels.
The Revenue of HARTE-HANKS INC (HHS) is expected to decline by -0.64% in the next year. Check the estimates tab for more information on the HHS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HHS does not pay a dividend.
HARTE-HANKS INC (HHS) will report earnings on 2025-03-13, after the market close.
The PE ratio for HARTE-HANKS INC (HHS) is 2.64. This is based on the reported non-GAAP earnings per share of 1.91 and the current share price of 5.05 USD. Check the full fundamental report for a full analysis of the valuation metrics for HHS.
The outstanding short interest for HARTE-HANKS INC (HHS) is 0.58% of its float. Check the ownership tab for more information on the HHS short interest.
ChartMill assigns a fundamental rating of 4 / 10 to HHS. While HHS seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months HHS reported a non-GAAP Earnings per Share(EPS) of 1.91. The EPS decreased by -30.55% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -27.6% | ||
ROE | -141.76% | ||
Debt/Equity | 0.02 |
ChartMill assigns a Buy % Consensus number of 80% to HHS. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of -729.87% and a revenue growth -0.64% for HHS